Skip to main content

Advances in Cancer Medicine: Our Momentum of Discovery

 

Featured Content |Content Library

Dana-Farber Cancer Institute Raises More Than $2 Billion in Record-Breaking Fundraising Campaign to Defy Cancer News

Dana-Farber Cancer Institute Raises More Than $2 Billion in Record-Breaking Fundraising Campaign to Defy Cancer

Long-term Metastatic Melanoma Survival Dramatically Improves on Immunotherapy News

Long-term Metastatic Melanoma Survival Dramatically Improves on Immunotherapy

Dana-Farber Cancer Institute Leads the Launch of IGNITE Consortium to Eradicate Health Inequities in Pediatric Cancer Care News

Dana-Farber Cancer Institute Leads the Launch of IGNITE Consortium to Eradicate Health Inequities in Pediatric Cancer Care

Prostate Cancer Vaccines: What’s the Latest? News

Prostate Cancer Vaccines: What’s the Latest?

Dana-Farber/Boston Children's Ranked Among the Best Pediatric Cancer Programs in the Nation for 18th Year in a Row News

Dana-Farber/Boston Children's Ranked Among the Best Pediatric Cancer Programs in the Nation for 18th Year in a Row

Antibody-Drug Conjugate Found Effective Against Brain Metastases in Patients with HER2-Positive Breast Cancer News

Antibody-Drug Conjugate Found Effective Against Brain Metastases in Patients with HER2-Positive Breast Cancer

Education/CME

Receive Dana-Farber's e-newsletter, Momentum, to learn of advances in cancer research and care, current clinical trials, and upcoming CME programs.

 
Season two of Dana-Farber's podcast, Unraveled, is now available. Listen Now